Efficacy Of Royal Philips Electronics N.V.' Stellarex .035" Low-Dose Drug-Coated Balloon Demonstrated In Clinical Trial At Two Years - BioLegacy Research

Efficacy Of Royal Philips Electronics N.V.' Stellarex .035" Low-Dose Drug-Coated Balloon Demonstrated In Clinical Trial At Two Years

Post author:Sam
Post published:September 14, 2017
Post category:BioPharma

Life Sciences Jobs …
Source: BioSpace